Question 1

Is Alaunos Therapeutics, Inc. TCRT stock halal to invest in?

Accepted Answer

No. As of February 2026, Alaunos Therapeutics (TCRT) does not pass AAOIFI Shariah screening because interest-bearing investments exceeds the permitted limits. AAOIFI Standard No. 21 caps non-permissible income at 5% of revenue, and interest-bearing debt and investments at 30% of market capitalisation each. We re-screen monthly, so the status can change. Check the live verdict in the Tabadulat app.

Question 2

How often is Alaunos Therapeutics, Inc. TCRT reviewed for Shariah compliance?

Accepted Answer

Tabadulat re-screens Alaunos Therapeutics (TCRT) every month. Each review applies AAOIFI Shariah Standard No. 21 to the latest financial data: business activity, non-permissible income, interest-bearing investments and debt, and preference shares. Our Shariah Supervisory Board oversees the process. Ratios move with the market, so a verdict can change. App users are alerted if a holding turns non-compliant.

Question 3

Does Alaunos Therapeutics, Inc. TCRT pass the AAOIFI Non Permissible Income criteria?

Accepted Answer

Yes. Alaunos Therapeutics's income from non-permissible sources stays below AAOIFI's 5% ceiling in the February 2026 screening. The screen covers interest, conventional finance, alcohol, gambling and tobacco. Small incidental amounts are allowed, but they must be purified: investors donate that share of dividends to charity. We re-check this screen every month.

Question 4

Does Alaunos Therapeutics, Inc. TCRT pass the AAOIFI Interest Bearing Investments criteria?

Accepted Answer

No. In the February 2026 screening, Alaunos Therapeutics's interest-bearing investments are above AAOIFI's 30% market-capitalisation limit, so this screen currently fails. The ratio moves with the share price as well as the balance sheet. We re-screen every month, and the result can change.

Question 5

Does STOCK  pass the AAOIFI Interest Bearing Debt criteria?

Accepted Answer

Yes. Alaunos Therapeutics's interest-bearing debt stays below 30% of market capitalisation in the February 2026 screening, inside the AAOIFI limit. The cap limits shareholders' exposure to interest-based leverage. Because market capitalisation changes daily, the ratio can drift without any new borrowing. We re-screen every month.

Question 6

How can I check the latest Shariah compliance status of Alaunos Therapeutics, Inc. stock?

Accepted Answer

No purification factor applies to Alaunos Therapeutics (TCRT) right now. Factors are published only for stocks that pass AAOIFI screening, and TCRT currently does not. Purification (Tazkiyah) means donating the small impure share of dividend income to charity. If TCRT returns to compliance in a monthly review, its factor is published again.

Question 7

Can the Shariah compliance status of Alaunos Therapeutics, Inc. stock change?

Accepted Answer

Yes. Alaunos Therapeutics has no impermissible preference share structure, so it passes this AAOIFI screen as of February 2026. Preference shares promise holders fixed or priority dividends ahead of ordinary shareholders. That conflicts with the Shariah principle of sharing profit and loss in proportion to ownership. The screen is verified in every monthly review.

Is Alaunos Therapeutics (TCRT) stock Halal?

Frequently asked questions